Pawel MK, Kamachi T, Kumar M, Yoshizawa K
Its crucial to communicate with your healthcare provider about any persistent or severe symptoms, as they can provide guidance on managing these effects
& Smith, E
The pharmaceutical versions amplify and extend these effects
Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S (2020) Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and Cardiovascular Diseases
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) mimic this hormone to slow gastric emptying, reducing appetite and curbing food cravings